Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 11/2013

01-11-2013 | Research Article

The application of ultrasonic harmonic scalpel in the radical surgery of gastric cancer

Authors: Y. Huang, G. C. Mu, X. G. Qin, J. L. Lin, C. Liu, Z. B. Chen, Y. J. Zeng

Published in: Clinical and Translational Oncology | Issue 11/2013

Login to get access

Abstract

Purpose

Ultrasonic harmonic scalpel has been widely applied to laparoscopic surgery of gastric cancer, but it has not been evaluated properly in open surgery. The objective of this study was to evaluate the value of the ultrasonic harmonic scalpel in the open radical surgery of gastric cancer.

Methods

106 gastric cancer patients who had accepted distal D2 lymphadenectomy were included in this study. Patients were divided into ultrasonic harmonic scalpel (UHS) surgery group (50 cases) and conventional electric scalpel surgery group (56 cases). UHS surgery group patients were accepted surgery by ultrasonic harmonic scalpel. Instead, conventional electric scalpel surgery group patients were accepted surgery by monopolar electrocautery shovel and other traditional instruments. Then the average operation time, intra-operative blood loss, number of harvested lymph nodes, average post operative drainage within 3 days, and postoperative hospital stay were collected and compared between the two groups.

Results

The average operation time, blood loss, postoperative hospital stay in UHS group were significantly lower than traditional group (P < 0.05). The number of lymph node dissection was significantly higher than conventional surgery group (P < 0.05). There were no difference between two groups in average drainage within 3 days after surgery and the hospitalization costs (P > 0.05). In the presence of atherosclerotic patients, the average operation time, blood loss in UHS surgery group were significantly lower than the traditional group (P < 0.05).

Conclusion

Ultrasonic harmonic scalpel may have better effect in the radical surgery of gastric cancer patients. It meets the requirements of the future development of precise surgical procedure.
Literature
1.
Malekzadeh R, Nasseri-Moghaddam S. Reducing gastric cancer mortality in developing countries: learning from the experience in Japan. Arch Iran Med. 2008;11(5):588–90.PubMed
2.
Sun X, Mu R, Zhou Y, Dai X, Zhang S, Huang F, et al. Analysis of mortality rate of stomach cancer and its trend in twenty years in China. China J oncol. 2004;26(1):4–9.
3.
Skoropad VIu, Berdov BA. D2 lymphadenectomy for surgical and combined treatment of the gastric cancer. Khirurgiia (Mosk) 2010;(4):26–29.
4.
Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver.3). Gastric Cancer. 2011;14(2):113–23.CrossRef
5.
Barbour AP, Rizk NP, Gonen M, Tang L, Bains MS, Rusch VW, et al. Lymphadenectomy for adenocarcinoma of the gastroesophageal junction (GEJ): impact of adequate staging on outcome. Ann Surg Oncol. 2007;14(2):306–16.PubMedCrossRef
6.
Yonemura Y, Wu CC, Fukushima N, Honda I, Bandou E, Kawamura T, et al. Randomized clinical trial of D2 and extended paraaortic lymphadenectomy in patients with gastric cancer. Int J Clin Oncol. 2008;13(2):132–7.PubMedCrossRef
7.
Lee KY, Noh SH, Hyung WJ, Lee JH, Lah KH, Choi SH, et al. Impact of splenectomy for lymph node dissection on long-term surgical outcome in gastric cancer. Ann Surg Oncol. 2001;8(5):402–6.PubMedCrossRef
8.
Maruyama K, Gunven P, Okabayashi K, Sasako M, Kinoshita T. Lymph node metastases of gastric cancer. General pattern in 1931 patients. Ann Surg. 1989;210(5):596–602.PubMedCrossRef
9.
Hiatt JR, Gabbay J, Busuttil RW. Surgical anatomy of the hepatic arteries in 1000 cases. Ann Surg. 1994;220:50–2.PubMedCrossRef
10.
Albanese AM, Albanese EF, Miño JH, Gómez E, Gómez M, Zandomeni M, et al. Peritoneal surface area: measurements of 40 structures covered by peritoneum: correlation between total peritoneal surface area and the surface calculated by formulas. Surg Radiol Anat. 2009;31(5):369–77.PubMedCrossRef
Metadata
Title
The application of ultrasonic harmonic scalpel in the radical surgery of gastric cancer
Authors
Y. Huang
G. C. Mu
X. G. Qin
J. L. Lin
C. Liu
Z. B. Chen
Y. J. Zeng
Publication date
01-11-2013
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 11/2013
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-013-1026-0

Other articles of this Issue 11/2013

Clinical and Translational Oncology 11/2013 Go to the issue

Educational Series – BLUE SERIES

Has discovery-based cancer research been a bust?

Research Article

Estimate of the accelerated proliferation by protein tyrosine phosphatase (PTEN) over expression in postoperative radiotherapy of head and neck squamous cell carcinoma

Brief Research Article

Chemotherapy management of malignant pleural mesothelioma: a phase II study comparing two popular chemotherapy regimens

Research Article

VEGF and TSP1 levels correlate with prognosis in advanced non-small cell lung cancer

Research Article

Definitive radiotherapy for T1 glottic squamous cell carcinoma: a 15-year Cruces University Hospital experience

Research Article

Prognostic significance of annexin II expression in non-small cell lung cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits